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What does a name mean? Don
Quixote’s reply to Sancho Panza was
that a name is whatever you understand
it to mean. This response certainly
applies to the evolution of our thinking
about chemokines over the ten years of
their history. Initially perceived as sim-
ple chemoattractants, chemokines are
now implicated at diverse phases of the
immune response, and their signifi-
cance is becoming apparent in many
areas of biomedicine, including cancer,
HIV-1 infection, asthma, and cardio-
vascular disease.
Control of T-cell differentiation 
and trafficking
Mobilization of leukocytes from periph-
eral blood into tissues is an essential
requirement for immunity in higher
organisms. Extravasation of these cells
appears to be a highly regulated, multi-
step process involving coordinated inter-
actions between leukocytes, endothelial
cells, and chemoattractant molecules (1,
2). In the case of T cells, activation is ini-
tiated by recognizing antigens on the sur-
face of antigen-presenting cells (APCs).
Simultaneous costimulatory signals
from the APCs, such as those provided by
the interactions between the receptor
protein CD28 and its ligands CD80 and
CD86, are required for the T cell to pro-
liferate and become functionally special-
ized. The cytokines in the environment in
which T-cell activation takes place influ-
ence the outcome of the process. Thus,
IL-12 skews CD4 T-cell differentiation
toward a Th1 cell phenotype, in which
the cells produce IFN-γ and act mainly in
cell-mediated immune responses. On the
other hand, IL-4 leads CD4 T cells
toward the Th2 subset; these differenti-
ated cells produce IL-4, IL-5, IL-10, and
IL-13, and are involved in humoral
immunity, including allergic reactions.
The Th cell subsets are functionally dif-
ferent, and the Th1/Th2 cell balance
determines the outcome of immune
responses directed either at infected tis-
sue or, in the case of autoimmune dis-
ease, at otherwise healthy cells. As with
CD4 cells, CD8 T cells can differentiate
to Tc1 or Tc2 cell subsets. Although
cytokine production by Tc cell subtypes
corresponds to that of the Th subtypes,
Tc1 and Tc2 cells have cytotoxic activity.
The Th1/Th2 concept has been
instrumental in understanding how the
immune system works, and some of the
factors that influence Th1 or Th2
polarization have been identified. These
include the dendritic cells (DCs), a class
of APCs specialized in initiating T-cell
activation (3). In both humans and
mice, some DC subtypes have been
shown to promote distinct Th respons-
es. Human DC1 and mouse CD8α+
DCs induce Th1 polarization, which
has been linked to their IL-12–produc-
ing ability, whereas human DC2 and
mouse CD8α– DCs induce Th2 differ-
entiation (4, 5). The costimulatory sig-
nal provided by the DCs also partici-
pates in the Th1/Th2 polarization, as
recently shown for the inducible cos-
timulatory molecule, which binds
B7RP and favors Th2 differentiation
(6–8). Some of the STAT family pro-
teins are known to be necessary signal-
ing effectors for Th1/Th2 differentia-
tion. Induction of STAT4 by IL-12 is
required for developing fully function-
al Th1 cells (9, 10), whereas STAT6,
induced by IL-4, is similarly needed for
Th2 cell differentiation (11–13). Indeed,
the unbalanced T-cell responses of
STAT6- and STAT4-deficient mice
mimic those of IL-4– and IL-12–defi-
cient mice, respectively. Other tran-
scription factors such as T-bet (T-box
expressed in T cells) (14) and GATA-3
(15) are reported to participate in Th1
and Th2 cell differentiation, respective-
ly. Chemokines probably participate in
T-cell polarization, in view of their cen-
tral role in control of DC trafficking
and the fact that IL-4 and IL-12 induce
production of distinct chemokines (see
below). In addition, studies with 
CCL2-deficient mice show that this
chemokine is critical for development
of a Th2 response (16).
T-cell polarization activates expres-
sion of the cytokine genes that charac-
terize each Th cell subset, and modu-
lates expression of certain others; not
surprisingly, these include chemokine
receptor genes. In vitro T-cell differen-
tiation under conditions that favor
Th1 or Th2 polarization induces dif-
ferent sets of chemokine receptors,
with CXCR3 and CCR5 preferentially
expressed in Th1 cells, and CCR3,
CCR4, and CCR8 expressed in the Th2
cells (17). For this reason, chemokine
receptors have served as useful markers
in Th1/Th2 cell studies.
The preferential expression of distinct
chemokine receptor complements
implies that cells have different abilities
to target specific environments in
response to chemoattractant cues. In a
recent issue of the JCI, Kim et al. (18)
show that Bonzo/CXCR6, the newly
described receptor for the chemokine
CXCL16 (19), is a differential marker
for the Th1 and Tc1 cell subsets in vitro
and in vivo. In vitro–polarized Bonzo+
CD4 T or CD8 cells typically produce
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IFN-γ, and few of these cells express
CCR7, a chemokine receptor involved
in homing to and migration within
lymphoid tissues. Hence, Bonzo+ T cells
would be expected to migrate preferen-
tially to nonlymphoid destinations, and
indeed, arthritic synovial fluid and
inflamed liver are enriched for Bonzo+
T cells. As pointed out by Kim et al.
(18), T cells in inflamed synovial fluid
are efficient Th1 cytokine producers, so
these new data suggest a role for Bonzo
in T-cell homing to chronically
inflamed tissues. Consistent with the
preferential expression of Bonzo in Th1
cells, the authors also found that DCs
prime naive T cells to express Bonzo
and that Bonzo expression can be
increased by IL-12 and decreased by IL-
4. Moreover, Bonzo’s ligand, CXCL16,
is expressed by DCs (19), suggesting the
existence of a feedback mechanism to
amplify Th1 cell responses.
Integrating chemokine and 
cytokine signals
A number of studies have shown that
the ability of DCs to migrate to
inflamed areas and then to the draining
lymph nodes can be explained in terms
of a switch in the chemokine receptors
they express (17). Immature DCs main-
ly express receptors for inflammatory
chemokines such as CCR1, CCR2,
CCR5, and CCR6, which are then
downregulated as the DCs mature.
Mature DCs upregulate expression of
lymphoid-homing chemokine recep-
tors such as CCR7. Naive T cells also
express CCR7, guiding them to lymph
nodes, where the CCR7 ligands CCL21
and CCL19 are expressed. Once they
reach the lymph nodes, these cells
require contact with DCs in order to be
primed (20). DCs produce chemokines
such as CCL18, which binds a yet
unknown receptor in naive T cells, as
well as CCL17 and CCL22, which bind
CCR4, a chemokine receptor expressed
by a memory T-cell subset. The impor-
tance of coordinated cell movements to
the outcome of the immune response
was clearly illustrated in a recent study
on CCR7 expression in spleen Th1 and
Th2 cells (21). Naive and Th1 cells
express CCR7 and home to the periar-
teriolar lymphoid sheath, whereas Th2
cells, which do not express CCR7, home
to the periphery of T-cell zones, in the
vicinity of B-cell follicles. Forced expres-
sion of CCR7 in Th2 cells results in a
Th1-like splenic localization pattern
and yields Th2 cells that are impaired in
their ability to help B cells in vivo.
Growing evidence points toward the
existence of an intricate network con-
necting chemokine and cytokine signal-
ing in the regulation of the immune
response (22). Cytokines have been
shown to promote chemokine expres-
sion; for instance, IFN-γ induces pro-
duction of CXCL9 and CXCL10, which
attract Th1 cells through their interac-
tion with CXCR3. Similarly, the Th2
cytokines IL-4 and IL-13 stimulate
CCL11 production, resulting in
chemoattraction of CCR3-expressing
Th2 cells. Chemokines such as CCL4
and CCL5, which bind CCR5, induce 
IL-12 production in the CD8α+ DC sub-
set (23), thus influencing their subse-
quent immunological function. Future
studies will uncover new transcription
factors that participate in Th1 and Th2
differentiation, as well as details of the
genetic programs they activate, and they
will provide a more complete picture of
the molecular elements participating in
T-cell polarization.
The current identification of a
Bonzo+ subpopulation will allow stud-
ies of a T-cell subtype apparently spe-
cialized in homing to highly inflamed
tissues. Other T-cell subtypes with
novel differentiation pathways and spe-
cialized functions remain to be discov-
ered, and new roles for chemokines in
these cells will undoubtedly come to
light as well. Only a decade has passed
since the discovery of the first
chemokine, but the variety and impor-
tance of these molecules in many phys-
iological and pathological situations
are being progressively unraveled. This
opens up the possibility of designing a
new generation of anti-inflammatory
drugs based on chemokine activities. It
will be exciting to see the clinical appli-
cations derived from this knowledge in
the next few years and to learn what fur-
ther surprises the chemokines and their
receptors hold in store for us.
1. Springer, T.A. 1994. Traffic signals for lymphocyte
recirculation and leukocyte migration: the multi-
step paradigm. Cell. 76:301–314.
2. Sánchez-Madrid, F., and del Pozo, M.A. 1999.
Leukocyte polarization in cell migration and
immune interactions. EMBO J. 18:501–511.
3. Banchereau, J., and Steinman, R.M. 1998. Den-
dritic cells and the control of immunity. Nature.
392:245–252.
4. Rissoan, M.C., et al. 1999. Reciprocal control of T
helper cell and dendritic cell differentiation. Sci-
ence. 283:1183–1186.
5. Maldonado-López, R., et al. 1999. CD8α+ and
CD8α- subclasses of dendritic cells direct the
development of distinct T helper cells in vivo. J.
Exp. Med. 189:587–592.
6. Dong, C., et al. 2001. ICOS co-stimulatory recep-
tor is essential for T-cell activation and function.
Nature. 409:97–101.
7. McAdam, A.J., et al. 2001. ICOS is critical for
CD40-mediated antibody class switching. Nature.
409:102–105.
8. Tafuri, A., et al. 2001. ICOS is essential for effec-
tive T-cell responses. Nature. 409:105–109.
9. Thierfelder, W.E., et al. 1996. Requirement for
Stat4 in interleukin-12 mediated responses of
natural killers and T cells. Nature. 382:171–174.
10. Kaplan, M.H., Sun, Y.L., Hoey, T., and Grusby, M.J.
1996. Impaired IL-12 responses and enhanced
development of Th2 cells in Stat4-deficient mice.
Nature. 382:174–177.
11. Kaplan, M.H., Schindler, U., Smiley, S.T., and
Grusby, M.J. 1996. Stat6 is required for mediating
responses to IL-4 and for the development of Th2
cells. Immunity. 4:313–319.
12. Takeda, K., et al. 1996. Essential role of Stat6 in IL-
4 signaling. Nature. 380:627–630.
13. Shimoda, K., et al. 1996. Lack of IL-4 induced Th2
response and IgE class switching in mice with dis-
rupted Stat6 gene. Nature. 380:630–633.
14. Szabo, S.J., et al. 2000. A novel transcription fac-
tor, T-bet, directs Th1 lineage commitment. Cell.
100:655–669.
15. Zheng, W.P., and Flavell, R.A. 1997. The tran-
scription factor GATA-3 is necessary and suffi-
cient for Th2 cytokine gene expression in CD4 T
cells. Cell. 89:587–596.
16. Gu, L., et al. 2000. Control of Th2 polarization by
the chemokine monocyte chemoattractant pro-
tein-1. Nature. 404:407–411.
17. Sallusto, F., Mackay, C.R., and Lanzavecchia, A.
2000. The role of chemokine receptors in primary,
effector, and memory immune responses. Annu.
Rev. Immunol. 18:593–620.
18. Kim, C.H., et al. 2001. Bonzo/CXCR6 expression
defines type 1–polarized T-cell subsets with extra-
lymphoid tissue homing potential. J. Clin. Invest.
107:595–601.
19. Matloubian, M., David, A., Engel, S., Ryan, J.E.,
and Cyster, J.G. 2000. A transmembrane CXC
chemokine is a ligand for HIV-coreceptor Bonzo.
Nature Immunology. 1:298–304.
20. Cyster, J.G. 1999. Chemokines and cell migration
in secondary lymphoid organs. Science.
286:2098–2102.
21. Randolph, D.A., Huang, G., Carruthers, C.J.L.,
Bromley, L.E., and Chaplin, D.D. 1999. The role of
CCR7 in Th1 and Th2 cell localization and deliv-
ery of B cell help in vivo. Science. 286:2159–2162.
22. Mackay, C.R. 2001. Chemokines: immunology’s
high impact factors. Nature Immunology. 2:95–101.
23. Aliberti, J., et al. 2000. CCR5 provides a signal for
microbial induced production of IL-12 by CD8α+
dendritic cells. Nature Immunology. 1:83–87.
792 The Journal of Clinical Investigation | April 2001 | Volume 107 | Number 7
Downloaded from http://www.jci.org on May 27, 2016.   http://dx.doi.org/10.1172/JCI12608
